| [1] |
焦蒙, 杨娟. 环境介质中防晒剂的残留与毒性研究进展[J]. 中国环境监测, 2024, 40(4): 19-29.
|
| [2] |
European Commission. Amending regulation (EC) No 1223/2009 of the european parliament and of the council as regards the use of vitamin A, alpha-arbutin and arbutin and certain substances with potential endocrine disrupting properties in cosmetic products[EB/OL]. (2024-04-04) [2025-02-10]. https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=OJ:L_202400996&qid=1712630515873.
|
| [3] |
European Chemicals Agency. (Member state committee support document for identification of (±)-1, 7, 7-trimethyl-3-[(4-methylphenyl)methylene]bicyclo[2.2.1]heptan-2-one covering any of the individual isomers and/or combinations thereof (4-mbc) as a substance of very high concern because of its endocrine disrupting properties (article 57(f)-human health)[EB/OL]. (2021-11-29) [2025-02-10]. https://echa.europa.eu/documents/10162/6a6d37ea-30ea-5cc5-74f7-6c1f6e678fc0.
|
| [4] |
Scientific Committee on Consumer Products. Opinion on 4-methylbenzylidene camphor[EB/OL]. (2006-10-10) [2025-02-10]. .
|
| [5] |
塔娜, 冯孟鑫, 高家敏, 等. 潜在内分泌干扰风险防晒剂的监管及其使用情况分析[J]. 日用化学工业(中英文), 2024, 54(3): 337-343.
|
| [6] |
刘小娟, 张弦, 周桓, 等. 2015-2019年防晒类化妆品中防晒剂的使用情况分析[J]. 广州化工, 2020, 48(24): 78-80.
|
| [7] |
Kerr A C. A survey of the availability of sunscreen filters in the UK[J]. Clinical and Experimental Dermatology, 2011, 36(5): 541-543.
doi: 10.1111/j.1365-2230.2010.04007.x
pmid: 21434977
|
| [8] |
Poiger T, Buser H R, Balmer M E, et al. Occurrence of UV filter compounds from sunscreens in surface waters: regional mass balance in two swiss lakes[J]. Chemosphere, 2004, 55(7): 951-963.
pmid: 15051365
|
| [9] |
Manová E, Von G N, Hauri U, et al. Organic UV filters in personal care products in switzerland: a survey of occurrence and concentrations[J]. International Journal of Hygiene and Environmental Health, 2013, 216(4): 508-514.
doi: 10.1016/j.ijheh.2012.08.003
pmid: 23026542
|
| [10] |
Fent K, Zenker A, Rapp M. Widespread occurrence of estrogenic UV-filters in aquatic ecosystems in Switzerland[J]. Environmental Pollution, 2010(158): 1817-1824.
|
| [11] |
Díaz-cruz M S, Gago-ferrero P, Llorca M, et al. Analysis of UV filters in tap water and other clean waters in Spain[J]. Analytical and Bio Analytical Chemistry, 2012, 402(7): 2325-2333.
|
| [12] |
Plagellat C, Kupper T, Furrer R, et al. Concentrations and specific loads of UV filters in sewage sludge originating from a monitoring network in Switzerland[J]. Chemosphere, 2006, 62(6): 915-925.
pmid: 15996716
|
| [13] |
The Scientific Committee on Cosmetic Products and Nonfood Products Intended for Consumers. Opinion concerning 4-methylbenzylidene camphor[EB/OL]. (2004-05-25) [2025-02-10]. https://ec.europa.eu/health/ph_risk/committees/sccp/documents/out282_en.pdf.
|
| [14] |
Scientific Committee on Consumer Products. Opinion on 4-methylbenzylidene camphor[EB/OL]. (2022-04-29) [2025-02-10]. https://health.ec.europa.eu/document/download/bc7fc1c9-9a5e-4f7c-a67f-a03b4dea312b_en?filename=sccs_o_262.pdf.
|
| [15] |
Seidlová-wuttke D, Christoffel J, Rimoldi G, et al. Comparison of effects of estradiol with those of octylmethoxycinnamate and 4-methylbenzylidene camphor on fat tissue, lipids and pituitary hormones[J]. Toxicology and Applied Pharmacology, 2006, 214(1): 1-7.
pmid: 16368123
|
| [16] |
Carou M E, Szwarcfarb B, Deguiz M L, et al. Impact of 4-methylbenzylidene camphor (4-mbc) during embryonic and fetal development in the neuroendocrine regulation of testicular axis in prepubertal and peripubertal male rats[J]. Experimental and Clinical Endocrinology & Diabetes, 2009, 117: 449-454.
|
| [17] |
Carou M E, Deguiz M L, Reynoso R, et al. Impact of the UV-B filter 4-(methylbenzylidene)-camphor (4-mbc) during prenatal development in the neuroendocrine regulation of gonadal axis in male and female adult rats[J]. Environmental Toxicology and Pharmacology, 2009, 27: 410-414.
doi: 10.1016/j.etap.2009.01.007
pmid: 21783972
|
| [18] |
Maerkel K, Durrer S, Henseler M, et al. Sexually dimorphic gene regulation in brain as a target for endocrine disrupters: developmental exposure of rats to 4-methylbenzylidene camphor[J]. Toxicology and Applied Pharmacology, 2007, 218: 152-165.
pmid: 17188730
|
| [19] |
Faass O, Schlumpf M, Reolon S, et al. Female sexual behavior, estrous cycle and gene expression in sexually dimorphic brain regions after pre- and postnatal exposure to endocrine active UV filters[J]. Neurotoxicology, 2009, 30(2): 249-260.
doi: 10.1016/j.neuro.2008.12.008
pmid: 19150460
|
| [20] |
Scientific Committee on Cosmetic Products and Nonfood Products Intended for Consumers. Opinion of the scientific committee on cosmetic and non-food products intended for consumers concerning 3-(4'-methylbenzylidene)-D, L camphor adopted by the plenary session of January 21, 1998[EB/OL]. (1998-01-21) [2025-02-10]. https://ec.europa.eu/health/scientific_committees/consumer_safety/opinions/sccnfp_opinions_97_04/sccp_out27_en.htm.
|
| [21] |
Scientific Committee on Cosmetic Products and Nonfood Products Intended for Consumers. Opinion on the evaluation of potentially estrogenic effects of UV-filters adopted by the SCCNFP during the 17th plenary meeting of 12 June 2001 [EB/OL]. (2001-06-12) [2025-02-10]. https://ec.europa.eu/health/scientific_committees/consumer_safety/opinions/sccnfp_opinions_97_04/sccp_out145_en.htm.
|
| [22] |
Scientific Committee on Consumer Products. Opinion on 4-methylbenzylidene camphor (4-MBC)[EB/OL]. (2008-06-24) [2025-02-10]. https://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_141.pdf.
|
| [23] |
Federal Reserve System Board of Governor. Code of federal regulation title 21 chapter i subchapter d part 352 sunscreen drug products for over-the-counter human use [stayed indefinitely][EB/OL]. (2004-06-04) [2025-02-10]. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-D/part-352.
|
| [24] |
European Commission. Regulation (EC) No 1223/2009 of the European parliament and of the council of 30 November 2009 on cosmetic products[EB/OL]. (2009-12-22) [2025-02-10]. https://ec.europa.eu/health/sites/default/files/endocrine_disruptors/docs/cosmetic_1223_2009_regulation_en.pdf.
|
| [25] |
Health Canada. Guidance document sunscreen monograph[EB/OL]. (2012-11-16) [2025-02-10]. https://www.canada.ca/en/healthcanada/services/drugs-health-products/public-involvementconsultations/natural-health-products/draft-guidance-documentsunscreen-monograph-consultation-document.html#a3.2.
|
| [26] |
Australian Government Department of Health Therapeutic Goods Administration. Australian regulatory guidelines for sunscreens[EB/OL]. (2021-07) [2025-02-10]. file:///C:/Users/lenovo/Downloads/australian-regulatory-guidelines-for-sunscreens%20(1).pdf.
|
| [27] |
何欢, 孙磊, 温雪华, 等. 日本防晒产品的管理制度及对我国的启示[J]. 日用化学工业(中英文), 2023, 53(8): 935-944.
|
| [28] |
周静, 顾宇翔, 葛宇, 等. 东盟化妆品相关法规和指令的研究[J]. 香料香精化妆品, 2016(6): 59-64.
|
| [29] |
Association of Southeast Asian Nations. ASEAN cosmetic directive annex VII: list of permitted UV filters which cosmetic products may contain[EB/OL]. (2024-12) [2025-02-10]. https://www.hsa.gov.sg/docs/default-source/hprg-cosmetics/annexes-of-the-aseancosmetic-directive-(updated-dec24).pdf?sfvrsn=26e48430_5.
|
| [30] |
国家食品药品监督管理总局. 总局关于实施化妆品安全技术规范(2015年版)有关事宜的公告[EB/OL]. (2016-06-01) [2025-02-10]. https://www.nmpa.gov.cn/xxgk/ggtg/hzhpggtg/jmhzhptg/20160601173701337.html.
|
| [31] |
国家食品药品监督管理总局. 化妆品安全技术规范(2015年版)[S]. 北京: 人民卫生出版社, 2015.
|
| [32] |
塔娜, 高家敏, 张凤兰, 等. 欧盟对内分泌干扰物质的监管及其启示[J]. 香料香精化妆品, 2023(2): 5-11.
|
| [33] |
Solecki R, Kortenkamp A, Bergman A, et al. Scientific principles for the identification of endocrine-disrupting chemicals: a consensus statement[J]. Archives of Toxicology, 2017, 91(2): 1001-1006.
doi: 10.1007/s00204-016-1866-9
pmid: 27714423
|
| [34] |
高立雪, 张卫强, 喻晓毅. 防晒化妆品中的防晒剂使用频度分析[J]. 现代预防医学, 2011, 38(10): 1324-1332.
|